Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Oncology Nursing Forum
|
March 11, 2009
Case-control study to evaluate predictors of lymphedema after breast cancer surgery
Karen K Swenson, Mary Jo Nissen, Joseph W Leach, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
April 3, 2012
Radon testing and mitigation: an intervention in a primary care setting
Mary Jo Nissen, Joseph W Leach, Julia A Nissen, et al.
Journal of Surgical Oncology
|
April 22, 2016
Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy
Srinevas K Reddy, Robin J Parker, Joseph W Leach, et al.
The Breast Journal
|
February 25, 2018
Clinicopathologic analysis of a large series of microinvasive breast cancers
Tamera J Lillemoe, Michaela L Tsai, Karen K Swenson, et al.
American Journal of Clinical Oncology
|
May 8, 2012
A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates
Vivek Thumbigere-Math, Lam Tu, Sabrina Huckabay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 8, 2018
Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study
Taofeek K Owonikoko, Suzanne E Dahlberg, Gabriel L Sica, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
August 19, 2009
Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients
Vivek Thumbigere-Math, Ma'ann C Sabino, Rajaram Gopalakrishnan, et al.
Gynecologic Oncology
|
July 15, 2014
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer
Ignace Vergote, Russell J Schilder, Charles H Pippitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT)
Lynne I Wagner, Fengmin Zhao, Fangxin Hong, et al.
Cancer Medicine
|
August 30, 2020
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial
Laurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Oncology Nursing Forum
|
March 11, 2009
Case-control study to evaluate predictors of lymphedema after breast cancer surgery
Karen K Swenson, Mary Jo Nissen, Joseph W Leach, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
April 3, 2012
Radon testing and mitigation: an intervention in a primary care setting
Mary Jo Nissen, Joseph W Leach, Julia A Nissen, et al.
Journal of Surgical Oncology
|
April 22, 2016
Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy
Srinevas K Reddy, Robin J Parker, Joseph W Leach, et al.
The Breast Journal
|
February 25, 2018
Clinicopathologic analysis of a large series of microinvasive breast cancers
Tamera J Lillemoe, Michaela L Tsai, Karen K Swenson, et al.
American Journal of Clinical Oncology
|
May 8, 2012
A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates
Vivek Thumbigere-Math, Lam Tu, Sabrina Huckabay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 8, 2018
Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study
Taofeek K Owonikoko, Suzanne E Dahlberg, Gabriel L Sica, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
|
August 19, 2009
Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients
Vivek Thumbigere-Math, Ma'ann C Sabino, Rajaram Gopalakrishnan, et al.
Gynecologic Oncology
|
July 15, 2014
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer
Ignace Vergote, Russell J Schilder, Charles H Pippitt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT)
Lynne I Wagner, Fengmin Zhao, Fangxin Hong, et al.
Cancer Medicine
|
August 30, 2020
Patient-reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial
Laurie E Steffen McLouth, Fengmin Zhao, Taofeek K Owonikoko, et al.
Page
of 2